Non-Obstructive Coronary Artery DiseaseNCT05738876
Non Obstructive Versus Obstructive Coronary Artery Disease
An observational study of Non-Obstructive Coronary Artery Disease, run by Arab Board of Health Specializations, Iraq at 1 site in Iraq.
Trial summary
The goal of this observational study is to study the non obstructive type of ischemic heart disease by identifying unique clinical features , frequency and age group .in patient admitted in coronary care unit , suffered from angina or heart attack. . Read more about this study
- Who is it for?
- Ages 18 to 81 years
- Conditions the study is for
- Non-Obstructive Coronary Artery Disease
- What is being tested?
- CORONARY ANGIOGRAPHY
- Type of treatment
- Surgery or procedure
- How many people
- 167 participants
- Where
- 1 siteIraq
- Study dates
- 1 Jan 2022to 11 Feb 2023
- How long will I take part?
- 5 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 81 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: all patients with clinical features of IHD underwent coronary angiography in CCU of imam hussain hospital from January to May of 2021
Who may be able to join
- Patients diagnosed with IHD ( MI, unstable angina ,chronic stable angina)
- >18 years of age
- patients undergoing CAG for emergency or elective situations.
Who cannot join
- Patients who were hemodynamically unstable.
- patients with incomplete data
- patients with clinical features of pericarditis or others of non cardiac origin chest pain .
Trial locations and contacts
1 site in 1 country.
Iraq1 site
Arab board of health specializations-Iraq, Karbala , Iraq
Karbala, 56001
About this study
Official title: Non Obstructive Versus Obstructive Coronary Artery Disease Documented by Coronary Angiography; Prevalence & Diagnostic Features in a Single Center Experience : A Prospective Cross Sectional Study
The goal of this observational study is to study the non obstructive type of ischemic heart disease by identifying unique clinical features , frequency and age group .in patient admitted in coronary care unit , suffered from angina or heart attack. . The main question[s] it aims to answer are:
- how it different from classical type of ischemic heart disease ( obstructive coronary artery disease)
- what is frequency and age prevalence of these patient Participants evaluated by history , clinical examination, serum troponin and coronary angiography.
- Conditions
- Non-Obstructive Coronary Artery Disease
- Being tested
- CORONARY ANGIOGRAPHY
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CORONARY ANGIOGRAPHYProcedure or surgery
coronary angiography by femoral or radial artery access
What is being measured
The primary outcome is the main question the study is designed to answer.
Non obstructive versus obstructive coronary artery disease documented by coronary angiography; prevalence & diagnostic features in a single center experience : A prospective cross sectional study
analysis of diagnostic features and frequency of non obstructive artery disease in comparison to obstructive artery disease
Measured: BASELINE
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Feb 2023
- Study start1 Jan 2022
- Primary completion1 May 2022
- Study completion11 Feb 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Non-Obstructive Coronary Artery DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 167 participants (actual)
- Target duration
- 5 Months
Sponsor and investigators
- Lead sponsor
- Arab Board of Health Specializations, Iraq
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hasanain Ali Al ftailah, Arab Board of Health Specializations, Iraq
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05738876
- Sponsor's protocol ID
- NOCAD diagnostic features
- Status last verified
- Feb 2023
- First submitted
- 13 Feb 2023
- Last updated
- 22 Feb 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Non Obstructive Versus Obstructive Coronary Artery Disease Documented by Coronary Angiography; Prevalence & Diagnostic Features in a Single Center Experience : A Prospective Cross Sectional Study
- ClinicalTrials.gov ID
- NCT05738876
- Acronym / sponsor ID
- NOCAD diagnostic features
- Conditions
- Non-Obstructive Coronary Artery Disease
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 167 participants (actual)
- Lead sponsor
- Arab Board of Health Specializations, IraqUniversity, hospital or other
- Study start
- 1 Jan 2022 (actual)
- Primary completion
- 1 May 2022 (actual)
- Study completion
- 11 Feb 2023 (actual)
- First posted
- 22 Feb 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to study the non obstructive type of ischemic heart disease by identifying unique clinical features , frequency and age group .in patient admitted in coronary care unit , suffered from angina or heart attack. . The main question[s] it aims to answer are:
- how it different from classical type of ischemic heart disease ( obstructive coronary artery disease)
- what is frequency and age prevalence of these patient Participants evaluated by history , clinical examination, serum troponin and coronary angiography.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 5 Months
Who may qualify
- Ages
- 18 to 81 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- all patients with clinical features of IHD underwent coronary angiography in CCU of imam hussain hospital from January to May of 2021
Key inclusion criteria (3 listed)
- Patients diagnosed with IHD ( MI, unstable angina ,chronic stable angina)
- >18 years of age
- patients undergoing CAG for emergency or elective situations.
Key exclusion criteria (3 listed)
- Patients who were hemodynamically unstable.
- patients with incomplete data
- patients with clinical features of pericarditis or others of non cardiac origin chest pain .
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CORONARY ANGIOGRAPHYcoronary angiography by femoral or radial artery access | Procedure or surgery | – |
Primary outcome
Non obstructive versus obstructive coronary artery disease documented by coronary angiography; prevalence & diagnostic features in a single center experience : A prospective cross sectional study
Time frame: BASELINE
analysis of diagnostic features and frequency of non obstructive artery disease in comparison to obstructive artery disease
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Feb 2023.
Related trials for Non-Obstructive Coronary Artery Disease
Active, not recruitingPhase 4
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Coronary Artery Disease
Active, not recruiting
Insulin Resistance and Coronary Microvascular Dysfunction in Patients With Myocardial Ischemia and Non-obstructive Coronary Artery Disease
Coronary Microvascular Dysfunction, Coronary Microvascular Disease
Active, not recruitingPhase 3
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
Coronary Artery Disease
Not yet recruiting
Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy
Hypertrophic Cardiomyopathy
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Non-Obstructive Coronary Artery Disease, run by Arab Board of Health Specializations, Iraq at 1 site in Iraq.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Non obstructive versus obstructive coronary artery disease documented by coronary angiography; prevalence & diagnostic features in a single center experience : A prospective cross sectional study (time frame: BASELINE). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2023.